Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Ltd Live Price Chart
Performance
| Previous Close | ₹ 555 |
| High | ₹ 559.1 |
| Volume | 47968 |
| 52W Range | ₹ 440 - ₹ 770 |
| Open | ₹ 559.1 |
| Low | ₹ 540.7 |
| Market Cap | ₹ 1131.18 Cr |
Lincoln Pharmaceuticals Ltd Technicals
| 20 Day | ₹ 571.039 |
| 50 Day | ₹ 589.654 |
| 100 Day | ₹ 597.822 |
| 200 Day | ₹ 595.426 |
| 20 Day | ₹ 574.933 |
| 50 Day | ₹ 598.768 |
| 100 Day | ₹ 606.908 |
| 200 Day | ₹ 591.460 |
Lincoln Pharmaceuticals Ltd Fundamentals
| ROCE | 15.178 |
| P/E Ratio | 11.350 |
| P/B Ratio | 1.440 |
| Industry P/E | 1.440 |
| Debt to Equity | 48.881 |
| ROE | 11.601 |
| EPS | 48.150 |
| Dividend Yield | 0.000 |
| Book Value | 378.254 |
| Face Value | 10.000 |
Lincoln Pharmaceuticals Ltd Financials
| Particulars | Y202603 | Y202503 | Y202403 | Y202303 | Y202203 |
|---|---|---|---|---|---|
| Total Revenue | 704.4839 | 645.7072 | 614.9721 | 532.7923 | 482.0766 |
| Total Expenses | 588.8589 | 536.5186 | 492.7295 | 432.337 | 386.1476 |
| Profit After Tax | 87.8938 | 82.3464 | 93.3049 | 72.8994 | 69.3549 |
Lincoln Pharmaceuticals Ltd Shareholding Pattern
| Promoter Holdings | 49.776 % |
| FIIs | 4.598 % |
| DIIs | 0.267 % |
| MutualFund | 0.002 % |
| Retail | 36.117 % |
| Others - | 9.239 % |
About Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Limited, was originally registered and formed as a Partnership Firm in January, 1979 to manufacture pharmaceutical formulations. The Firm was converted into a Public Company in January 1995 named 'Lincoln Pharmaceuticals Limited' . All the assets and business of the erstwhile partnership were transferred to the Company. The Company is engaged in the business of manufacturing and trading of pharmaceutical products. The focused area includes anti-infective, respiratory system, gynecology, cardio & CNS, anti-diabetic, anti malaria, among others. The Company was initially carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.'96 to part-finance its project. The Company launched Next Generation Progesterone Therapy 'ProlinSpray' during the year 2018. During the year 2021-22, Lincoln Parentera ...
Similar Stocks
| Ambalal Sarabhai Enterprises Ltd Pharmaceuticals | ₹ 37.79 -0.06 (-0.16%) |
| Amrutanjan Health Care Ltd Pharmaceuticals | ₹ 513.80 +7.8 (+1.54%) |
| Astrazeneca Pharma India Ltd Pharmaceuticals | ₹ 5,970.50 +33.5 (+0.56%) |
| Bliss GVS Pharma Ltd Pharmaceuticals | ₹ 652.00 -2.3 (-0.35%) |
| Abbott India Ltd Pharmaceuticals | ₹ 26,170.00 +100 (+0.38%) |
| Cipla Ltd Pharmaceuticals | ₹ 1,325.10 -2.9 (-0.22%) |
FAQs on Lincoln Pharmaceuticals Ltd
1. Can I buy Lincoln Pharmaceuticals Ltd from PL Capital? ›
2. Does Lincoln Pharmaceuticals Ltd pay dividends? ›
3. What is the current share price of Lincoln Pharmaceuticals Ltd ? ›
4. What is the 52-week high and low of Lincoln Pharmaceuticals Ltd ? ›
5. What is the market capitalisation of Lincoln Pharmaceuticals Ltd? ›
6. What is the current P/E ratio of Lincoln Pharmaceuticals Ltd? ›
7. What is the current P/B ratio of Lincoln Pharmaceuticals Ltd? ›
8. What is the shareholding pattern of Lincoln Pharmaceuticals Ltd? ›
9. What is the 1-year return of Lincoln Pharmaceuticals Ltd? ›
Start SIP in Lincoln Pharmaceuticals Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
